NCT02186275

Who might be able to join this trial:

• You have been diagnosed with Crohn's disease, confirmed through clinical assessments, a camera examination of the gut, and tissue samples
• You are between 9 and 18 years old at the time of joining the trial
• Your diagnosis was made between 2 weeks and 6 months before joining the trial
• Your Crohn's disease is currently considered mild or in low activity, based on a standard scoring system used for children (called the PCDAI score of 30 or below)
• You are already being treated with one or more standard Crohn's disease medications, such as steroids, nutritional therapy through a feeding tube or formula, azathioprine, 6-mercaptopurine, methotrexate, 5-ASA, infliximab, or adalimumab

Who may not be able to join:

• You have a severe and complex type of tunnel-like opening (fistula) near the back passage that was present at the time of diagnosis
• You have a known long-term liver condition involving a specific type of bile build-up in the body (confirm with trial site)
• You have known kidney problems that require regular dialysis, or your kidney function test results are above a certain level
• You have a known condition affecting bone development from birth
• You have cystic fibrosis or another condition that means your pancreas does not produce enough digestive enzymes
• You are currently taking certain anti-seizure medications that are processed by the body in a specific way (confirm with trial site)
• You are unable to swallow oral capsules

Important: Always verify eligibility with the trial site directly before applying.